User profiles for Markus Bitzer
Markus BitzerVerified email at med.umich.edu Cited by 8012 |
TGF-ß signaling in renal disease
EP Bo, M Bitzer - Journal of the American society of nephrology, 2002 - journals.lww.com
… We also found Smad3-dependent regulation of DAPK in murine podocytes (Markus Bitzer
and … Markus Bitzer is recipient of a research fellowship from the National Kidney Foundation of …
and … Markus Bitzer is recipient of a research fellowship from the National Kidney Foundation of …
[HTML][HTML] Apoptosis in podocytes induced by TGF-β and Smad7
Primary and secondary forms of focal segmental glomerulosclerosis (FSGS) are characterized
by depletion of podocytes and constitute a central manifestation of chronic progressive …
by depletion of podocytes and constitute a central manifestation of chronic progressive …
Genetic programs of epithelial cell plasticity directed by transforming growth factor-β
Epithelial–mesenchymal transitions (EMTs) are an essential manifestation of epithelial cell
plasticity during morphogenesis, wound healing, and tumor progression. Transforming …
plasticity during morphogenesis, wound healing, and tumor progression. Transforming …
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
M Bitzer, G von Gersdorff, D Liang… - Genes & …, 2000 - genesdev.cshlp.org
A number of pathogenic and proinflammatory stimuli, and the transforming growth factor-β (TGF-β)
exert opposing activities in cellular and immune responses. Here we show that the …
exert opposing activities in cellular and immune responses. Here we show that the …
[HTML][HTML] Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor
Transforming growth factor-β (TGF-β) signaling proceeds from the cell membrane to the
nucleus through the cooperation of the type I and II serine/threonine kinase receptors and their …
nucleus through the cooperation of the type I and II serine/threonine kinase receptors and their …
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker
…, JYC Lai, Y Zhou, JJ Hawkins, M Bitzer… - Science translational …, 2015 - science.org
Chronic kidney disease (CKD) affects 8 to 16% people worldwide, with an increasing incidence
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …
Defining cell-type specificity at the transcriptional level in human disease
…, F Eichinger, V Nair, JB Hodgin, M Bitzer… - Genome …, 2013 - genome.cshlp.org
Cell-lineage–specific transcripts are essential for differentiated tissue function, implicated in
hereditary organ failure, and mediate acquired chronic diseases. However, experimental …
hereditary organ failure, and mediate acquired chronic diseases. However, experimental …
Glomerular aging and focal global glomerulosclerosis: a podometric perspective
JB Hodgin, M Bitzer, L Wickman… - Journal of the …, 2015 - journals.lww.com
Kidney aging is associated with an increasing proportion of globally scarred glomeruli,
decreasing renal function, and exponentially increasing ESRD prevalence. In model systems, …
decreasing renal function, and exponentially increasing ESRD prevalence. In model systems, …
[HTML][HTML] An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy
It is important to find better treatments for diabetic nephropathy (DN), a debilitating renal
complication. Targeting early features of DN, including renal extracellular matrix accumulation (…
complication. Targeting early features of DN, including renal extracellular matrix accumulation (…
Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS
…, LS Higgins, AF List, M Bitzer… - Blood, The Journal …, 2008 - ashpublications.org
MDS is characterized by ineffective hematopoiesis that leads to peripheral cytopenias.
Development of effective treatments has been impeded by limited insight into pathogenic …
Development of effective treatments has been impeded by limited insight into pathogenic …